BACKGROUND: Age and host genetics are important determinants of malaria severity. Lymphotoxin-alpha (LTalpha) has been associated with the development of cerebral malaria (CM) and other severe malaria (SM) syndromes. Mutations in genes regulating LTalpha production contribute to other acute vascular diseases and may contribute to malaria pathogenesis. METHODS: We tested the association between rs7291467, a single-nucleotide polymorphism (SNP) in the LTalpha-related gene encoding galectin-2 (LGALS2), disease severity, and function in a case-control study of ethnic Highland Papuan adults and children with SM (n = 380) and asymptomatic malaria-exposed controls (n = 356) originating from a non-malaria-endemic region but residing in a lowland malaria-endemic area of Papua, Indonesia. RESULTS: The LGALS2 SNP showed a significant association with susceptibility to SM (including CM), in children (odds ratio, 2.02 [95% confidence interval, 1.14-3.57]) but not in adults. In SM, the C allele at rs7291467 was associated with enhanced galectin-2 transcript levels. In a separate group of Tanzanian children originating from a malaria-endemic region, we found preservation of the major ancestral LGALS2 allele and no association with susceptibility to CM. CONCLUSIONS: Results suggest differences in the inflammatory contribution to the development of SM between children and adults in the same population and potential differences between individuals originating from malaria-endemic and non-malaria-endemic areas.
BACKGROUND: Age and host genetics are important determinants of malaria severity. Lymphotoxin-alpha (LTalpha) has been associated with the development of cerebral malaria (CM) and other severe malaria (SM) syndromes. Mutations in genes regulating LTalpha production contribute to other acute vascular diseases and may contribute to malaria pathogenesis. METHODS: We tested the association between rs7291467, a single-nucleotide polymorphism (SNP) in the LTalpha-related gene encoding galectin-2 (LGALS2), disease severity, and function in a case-control study of ethnic Highland Papuan adults and children with SM (n = 380) and asymptomatic malaria-exposed controls (n = 356) originating from a non-malaria-endemic region but residing in a lowland malaria-endemic area of Papua, Indonesia. RESULTS: The LGALS2 SNP showed a significant association with susceptibility to SM (including CM), in children (odds ratio, 2.02 [95% confidence interval, 1.14-3.57]) but not in adults. In SM, the C allele at rs7291467 was associated with enhanced galectin-2 transcript levels. In a separate group of Tanzanian children originating from a malaria-endemic region, we found preservation of the major ancestral LGALS2 allele and no association with susceptibility to CM. CONCLUSIONS: Results suggest differences in the inflammatory contribution to the development of SM between children and adults in the same population and potential differences between individuals originating from malaria-endemic and non-malaria-endemic areas.
Authors: T Smith; H P Beck; A Kitua; S Mwankusye; I Felger; N Fraser-Hurt; A Irion; P Alonso; T Teuscher; M Tanner Journal: Trans R Soc Trop Med Hyg Date: 1999-02 Impact factor: 2.184
Authors: Arjen M Dondorp; Sue J Lee; M A Faiz; Saroj Mishra; Ric Price; Emiliana Tjitra; Marlar Than; Ye Htut; Sanjib Mohanty; Emran Bin Yunus; Ridwanur Rahman; Francois Nosten; Nicholas M Anstey; Nicholas P J Day; Nicholas J White Journal: Clin Infect Dis Date: 2008-07-15 Impact factor: 9.079
Authors: S H Hsieh; N W Ying; M H Wu; W F Chiang; C L Hsu; T Y Wong; Y T Jin; T M Hong; Y L Chen Journal: Oncogene Date: 2008-01-28 Impact factor: 9.867
Authors: Muhammad Karyana; Lenny Burdarm; Shunmay Yeung; Enny Kenangalem; Noah Wariker; Rilia Maristela; Ketut Gde Umana; Ram Vemuri; Maurits J Okoseray; Pasi M Penttinen; Peter Ebsworth; Paulus Sugiarto; Nicholas M Anstey; Emiliana Tjitra; Richard N Price Journal: Malar J Date: 2008-08-02 Impact factor: 2.979
Authors: Christian R Engwerda; Tracey L Mynott; Sanjeet Sawhney; J Brian De Souza; Quentin D Bickle; Paul M Kaye Journal: J Exp Med Date: 2002-05-20 Impact factor: 14.307
Authors: Ervi Salwati; Gabriela Minigo; Tonia Woodberry; Kim A Piera; Harini D de Silva; Enny Kenangalem; Emiliana Tjitra; Ross L Coppel; Ric N Price; Nicholas M Anstey; Magdalena Plebanski Journal: J Infect Dis Date: 2011-04-15 Impact factor: 5.226
Authors: Alberto Pinzon-Charry; Tonia Woodberry; Vivian Kienzle; Virginia McPhun; Gabriela Minigo; Daniel A Lampah; Enny Kenangalem; Christian Engwerda; J Alejandro López; Nicholas M Anstey; Michael F Good Journal: J Exp Med Date: 2013-07-08 Impact factor: 14.307
Authors: Nicholas M Douglas; Gysje J Pontororing; Daniel A Lampah; Tsin W Yeo; Enny Kenangalem; Jeanne Rini Poespoprodjo; Anna P Ralph; Michael J Bangs; Paulus Sugiarto; Nicholas M Anstey; Ric N Price Journal: BMC Med Date: 2014-11-18 Impact factor: 8.775
Authors: Damian A Oyong; Enny Kenangalem; Jeanne R Poespoprodjo; James G Beeson; Nicholas M Anstey; Ric N Price; Michelle J Boyle Journal: JCI Insight Date: 2018-11-15
Authors: Louise M Randall; Enny Kenangalem; Daniel A Lampah; Emiliana Tjitra; Esther D Mwaikambo; Tjandra Handojo; Kim A Piera; Zhen Z Zhao; Fabian de Labastida Rivera; Yonghong Zhou; Karli M McSweeney; Lien Le; Fiona H Amante; Ashraful Haque; Amanda C Stanley; Tonia Woodberry; Ervi Salwati; Donald L Granger; Maurine R Hobbs; Ric N Price; J Brice Weinberg; Grant W Montgomery; Nicholas M Anstey; Christian R Engwerda Journal: Malar J Date: 2010-10-29 Impact factor: 2.979